⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OGN News
Organon & Co.
Orogen Royalties Notes Initial Resource Estimate on Kodiak Copper's MPD Copper-Gold Project
accessnewswire.com
KDK
OGN
Organon To Present at the Piper Sandler 37th Annual Healthcare Conference
businesswire.com
OGN
Henlius and Organon Announce US FDA Approval of POHERDY ® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
businesswire.com
OGN
Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN
businesswire.com
OGN
Organon Reports Results for the Third Quarter Ended September 30, 2025
businesswire.com
OGN
New Data Show Early and Consistent Response to VTAMA ® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities
businesswire.com
OGN
Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN
prnewswire.com
OGN
Organon Announces Agreement to Divest its JADA ® System for Up to $465 Million to Laborie
businesswire.com
OGN
Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025
businesswire.com
OGN
Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN
businesswire.com
OGN